IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 28 X users

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

USE OF SIFNAR2 IN THE TREATMENT OF SARS-COV-2 INFECTION

Application WO-2023187244-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.